Nureca Limited has informed the Exchange regarding Outcome of Board Meeting held on May 20, 2025.
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited's board, meeting on May 20, 2025, approved the draft scheme of merger of its wholly owned subsidiary Nureca Technologies Private Limited into the listed parent company. Nureca Technologies had FY25 standalone revenue of Rs. 228.14 cr and net worth of Rs. 53.94 cr, against the parent's revenue of Rs. 1,146.40 cr and net worth of Rs. 1,917.38 cr. Because the transferor is wholly owned, no new shares will be issued and no share exchange ratio applies. Separately, the board approved the strike-off of Nureca Healthcare Private Limited, a non-material, non-functional wholly owned subsidiary with nil contribution to turnover or net worth, to simplify the group structure. Both actions are subject to statutory and regulatory approvals, including NCLT for the merger.
The merger is a straightforward internal restructuring with no share dilution and no cash consideration, so existing shareholders' economic interest remains unchanged. It may modestly improve operational efficiency and reduce compliance costs, but is unlikely to be a major stock price catalyst. The strike-off of the dormant healthcare subsidiary is housekeeping and has no material financial impact.